---
title: "Veru completes Phase 2b PLATEAU trial enrolling 250 patients for weight loss with Enobosarm and Semaglutide combo."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293932482.md"
description: "The US unemployment rate dropped to 5.4% in September, with the economy adding 194,000 jobs, surpassing expectations. Labor force participation rose slightly to 61.7%, indicating economic recovery and stability following the pandemic."
datetime: "2026-07-27T12:12:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293932482.md)
  - [en](https://longbridge.com/en/news/293932482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293932482.md)
generator: "portal-rs"
---

# Veru completes Phase 2b PLATEAU trial enrolling 250 patients for weight loss with Enobosarm and Semaglutide combo.

A recent report reveals that the unemployment rate in the United States has dropped to 5.4% in the month of September, which is a significant decrease from the previous month. The economy added 194,000 jobs, surpassing expectations and contributing to the overall improvement in the job market. This decrease in unemployment is a positive indicator of economic recovery from the impact of the global pandemic. The labor force participation rate also saw a slight increase to 61.7%, showing more people returning to the workforce. These numbers showcase a promising trend in the US labor market, signaling potential growth and stability in the economy.

### Related Stocks

- [VERU.US](https://longbridge.com/en/quote/VERU.US.md)

## Related News & Research

- [Veru Chief Scientific Officer Gary Barnette acquires $4,841.82 in common shares](https://longbridge.com/en/news/296143031.md)
- [History Says September Is the Worst Month for Stocks. Here's What Investors Should Actually Do.](https://longbridge.com/en/news/297169530.md)
- [VIB Vermögen: H1 2026 saw lower earnings but stable outlook, with new ventures and financial safeguards in place](https://longbridge.com/en/news/296988387.md)
- [Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September | TRNS Stock News](https://longbridge.com/en/news/297187500.md)
- [Ocugen to present modifier gene therapy platform at September investor conferences](https://longbridge.com/en/news/296902276.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**